Trial updateRetina
Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)
Not yet recruiting. Phase 3. Registered enrolment: 500. Ollin Biosciences, Inc.
Why it matters
Track this study through NCT07816315. No results are posted in this registry record.
The study at a glance
- Registry status
- Not yet recruiting
- Phase
- Phase 3
- Registered enrolment
- 500
- Results posted
- No
- Sponsor
- Ollin Biosciences, Inc.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.